Connect with us
Information

NORTH AMERICA EDITION
Australia
North America
World

Investing News Network Your trusted source for investing success

NORTH AMERICA EDITION
North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides
Button

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

Markets

Commodities

Currencies

Life Science Investing

Dyne Therapeutics Appoints Brian Posner to its Board of Directors

02 October

Life Science Investing

Dyne Therapeutics Receives Orphan Drug Designation in Japan for DYNE-251 in Duchenne Muscular Dystrophy

29 September

Life Science Investing

Dyne Therapeutics to Present at Upcoming Investor Conferences

27 August